http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2179849-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f509cf1e830bcb214ebc5bd5527bd0b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7958573fd6d133f7c0f8bca9240dab3a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
| filingDate | 1999-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f98266b3733fab1a5723317c1ef389d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e442ff8e338f7d4b37dd9c09ee3e957 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73ff63138f894f57ccbc197a0784c2ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fd70d4e15759baeb80caeb675d40fef |
| publicationDate | 2002-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2179849-C2 |
| titleOfInvention | Method to treat female recurrent genital herpes |
| abstract | FIELD: medicine, venerology. SUBSTANCE: the method puts forward to apply in combination Valtrex antiviral preparation, Neovir immunomodifying preparation and the one which has an impact upon urinary tract microflora - Acylact. Female patients are prescribed to use Valtrex per 0.5 g twice daily, a course lasts for 5 d, simultaneously Neovir is prescribed per 250 mg intramuscularly, 10 injections in 2 stages: the first 6 injections at 48-hlong interval, the last 4 injections at 7-d-long interval. When Valtrex intake is over, Acylact should be prescribed as vaginal suppositories per 5 doses daily, for nocturnal use, for 10 d. Before and after therapy a vaginal lysozymic activity is determined to evaluate the level of urinary tract biocenosis, vaginal pH, flora by calculating a total microbial amount (due to inoculation upon a bloody agar). EFFECT: prolonged terms of remission by 4-5 times in 75.9% female patients. 1 tbl _ |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2703708-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2651037-C1 |
| priorityDate | 1999-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.